Jump to content

LECO and Genedata Collaborate on Mass Spectrometry Data Analysis for High Resolution TOFMS Systems

Efficient mass spectrometry data analysis capabilities now available to a broad range of pharmaceutical, industrial biotech, and life science companies

September 25, 2012
St. Joseph, MI, USA and Basel, Switzerland

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, and LECO a global leader in analytical instrumentation and mass spectrometers, have announced their collaboration, which brings to market Genedata Expressionist® MSX software compatibility with LECO High Resolution TOFMS (HRT) instrumentation. Designed for complex sample analysis, LECO’s HRT technology provides acquisition speeds of up to 200 spectra/second, mass resolution up to 100,000 FWHM, and mass accuracy less than 1 ppm. Genedata Expressionist MSX is a comprehensive, end-to-end solution for the analysis of mass spectrometry data generated in metabolomics experiments.

“For LECO customers, it will be a great advantage to be able to utilize Genedata Expressionist MSX, together with our HRT platform, in their metabolomics applications,” said Dr. Jeff Patrick, director of Marketed Technology, LECO Separation Science. “We understand the unique challenges of metabolomics, and we are proud to provide instrumentation with the speed, sensitivity, resolution, and data-handling tools necessary to meet these challenges head-on. We look forward to a continued collaboration with Genedata that will effectively leverage our mutual capabilities.”

“With the ability to efficiently process raw MS data from LECO instrumentation, Genedata Expressionist MSX will enable scientists to quickly address a wide range of metabolomics questions, capitalizing on the high-performance of HRT output,” noted Dr. Othmar Pfannes, CEO of Genedata. “Our collaboration with LECO empowers researchers and advances innovative discovery in pharmaceutical, industrial biotechnology, and life science companies.”

About LECO Corporation
For more than 75 years, industries around the world have trusted LECO to deliver technologically advanced products and solutions. Today, that commitment continues with High Resolution Time-of-Flight Mass Spectrometry (TOFMS) for liquid and gas chromatography, as well as comprehensive two-dimensional gas chromatography (GCxGC), all featuring easy-to-use ChromaTOF® operating software. Product lines also include high-quality analytical instrumentation, metallography and optical equipment, and consumables. LECO has over 30 subsidiaries worldwide, with additional distributors authorized to sell or service LECO products to the rest of the world.
www.leco.com

About Genedata

Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
www.genedata.com
LinkedIn | Twitter | YouTube

Contact

Allison Kurz
Genedata
Public Relations
pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.


Genedata Expressionist MSX will enable scientists to quickly address a wide range of metabolomics questions, capitalizing on the high-performance of HRT output